Botanical pharmaceutical corporation HOME OUR COMPANY TECHNOLOGY PRODUCTS PIPELINE INVESTOR CENTER CAREERS CONTACT FR HOME  PRESS RELEASES  2021 Press Releases 2021 2020 2019 2018 2017 2016 2015 Corporate presentation Financial Reports Analysts Investor and Stock Information Media Corporate Governance What’s New Subscribe! First name Last name Company Email Press Releases NOVEMBER 30, 2021 DEVONIAN ANNOUNCES CLOSING OF AN OVERSUBSCRIBED PRIVATE PLACEMENT OF $10,000,000 NOVEMBER 25, 2021 DEVONIAN ANNOUNCES THE ISSUANCE OF SUBORDINATE VOTING SHARES IN SETTLEMENT OF A DEBT OWED TO A CONSULTANT AND THE GRANT OF STOCK OPTIONS NOVEMBER 15, 2021 DEVONIAN HEALTH GROUP ANNOUNCES CLOSING OF THE FIRST TRANCHE OF A PRIVATE PLACEMENT OF $2,292,199.50 NOVEMBER 04, 2021 DEVONIAN HEALTH GROUP ANNOUNCES ITS PARTICIPATION AT BIO-PARTNERING DURING JP MORGAN HEALTHCARE CONFERENCE 2022, BEING HELD VIRTUALLY ON JANUARY 10 TO 14, 2022 SEPTEMBER 30, 2021 DEVONIAN HEALTH GROUP ANNOUNCES APPOINTMENT OF MARTIN MOREAU AS VICE-PRESIDENT FINANCE AND AS A NEW MEMBER OF ITS BOARD OF DIRECTORS SEPTEMBER 13, 2021 DEVONIAN HEALTH GROUP ANNOUNCES CLOSING OF A PRIVATE PLACEMENT SEPTEMBER 09, 2021 DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS AUGUST 31, 2021 DEVONIAN HEALTH GROUP ANNOUNCES EXCLUSIVE DISTRIBUTION, SALES AND MARKETING AGREEMENT FOR PURGENESIS™ ANTI-AGING PRODUCTS IN MIDDLE EAST COUNTRIES AUGUST 26, 2021 DEVONIAN HEALTH GROUP INC. ANNOUNCES ITS PARTICIPATION AT VIRTUAL BIOPLUS INTERPHEX KOREA 2021 TO TAKE PLACE FROM AUGUST 31ST TO SEPTEMBER 15, 2021 JULY 28, 2021 DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER JULY 27, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES IN CHICAGO (USA) TODAY JULY 27, 2021 JULY 20, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES IN LOS ANGELES (USA) TODAY JULY 20, 2021 JUNE 14, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES FOR VANCOUVER TODAY JUNE 14, 2021 JUNE 03, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES FOR MONTREAL AND EAST OF CANADA TODAY JUNE 3RD, 2021 MAY 26, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES IN BOSTON (USA) TODAY MAY 26, 2021 MAY 13, 2021 DEVONIAN HEATH GROUP INC. TO PRESENT AT THE CANADA INDIA HEALTHCARE SUMMIT 2021 MAY 11, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON THURSDAY, MAY 13, 2021 APRIL 14, 2021 DEVONIAN HEALTH GROUP INC. RETAINS RENMARK FINANCIAL COMMUNICATIONS INC. TO PROVIDE INVESTOR RELATIONS SERVICES MARCH 30, 2021 DEVONIAN HEALTH GROUP ANNOUNCES NOTICE OF ALLOWANCE FOR A US PATENT APPLICATION COVERING USE OF THYKAMINE™ FOR THE TREATMENT OF CARDIOVASCULAR DISEASES MARCH 25, 2021 DEVONIAN HEALTH GROUP PROVIDES MORE DETAILS ON PREVIOUSLY ANNOUNCED POSITIVE TOPLINE RESULTS FROM PHASE 2 CLINICAL TRIAL OF THYKAMINE™ IN ADULT POPULATION WITH MILD-TO-MODERATE ATOPIC DERMATITIS AND THE GRANT OF STOCK OPTIONS MARCH 05, 2021 DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS FEBRUARY 18, 2021 DEVONIAN HEALTH GROUP ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 2 CLINICAL TRIAL OF THYKAMINE™ IN ADULT PATIENTS WITH MILD-TO-MODERATE ATOPIC DERMATITIS JANUARY 28, 2021 DEVONIAN HEALTH GROUP ANNOUNCES VOTING RESULTS OF THE ANNUAL GENERAL AND SPECIAL MEETING JANUARY 22, 2021 DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER FARM TO PHARM ® TERMS OF USE PRIVACY POLICY © 2020 DEVONIAN HEALTH GROUP INC. /**/